N
DTIL icon

Natixis’s Precision BioSciences DTIL Stock Holding History

Natixis’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-803
Closed -$8.8K – 1057
2023
Q4 		$8.8K Sell
803
-7
-0.9% -$75 ﹤0.01% 909
2023
Q3 		$8.29K Buy
810
+7
+0.9% +$108 ﹤0.01% 900
2023
Q2 		$12.7K Buy
+803
New +$18.4K ﹤0.01% 925

Other funds holding DTIL

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

Natixis's DTIL Position: Q1 2024 in Review

Natixis sold out of Precision BioSciences (DTIL) in Q1 2024, closing a stake of 803 shares — an estimated $8.8K sold.

Natixis first reported a position in DTIL in Q2 2023 and held it in 3 quarters. The position peaked at $12.7K in Q2 2023. 43 funds tracked by Wall St. Rank hold DTIL as of Q1 2024.

  • Natixis reported no remaining Precision BioSciences position as of Q1 2024 after selling out during the quarter.
  • Natixis sold 803 Precision BioSciences shares in Q1 2024, an estimated $8.8K.
  • Natixis first reported a position in Precision BioSciences in Q2 2023 and held it in 3 quarters.
  • Natixis's Precision BioSciences position peaked at $12.7K in Q2 2023.
  • 43 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2024.

Based on Natixis's 13F filing for Q1 2024, filed 13 May 2024.